Doheny Eye Institute
Brenda Stanton is an experienced professional in ocular disease evaluation and quality assurance, currently serving as Ocular Disease Evaluator II at Doheny Eye Institute since December 2020. Responsibilities include training new staff, performing document reviews, making final assessment calls, and assisting in the development of grading protocols. Previous roles at Doheny Eye Institute include Ocular Disease Evaluator I and QA/QC Coordinator. Prior experience includes working as a Cell Therapy Specialist at Kite Pharma, and various positions in quality assurance and control at Astellas Pharma and Helica Biosystems, Inc. Brenda Stanton holds a Bachelor of Science in Cell and Developmental Biology from California State University, Fullerton.
This person is not in any offices
Doheny Eye Institute
Doheny Eye Institute is an independent, non-profit organization whose mission is to further the conservation, improvement and restoration of human eyesight. Mrs. Carrie Estelle Doheny, wife of the prominent Los Angeles oilman Edward L. Doheny, lost the sight in her left eye at the age of 69. Suddenly aware of the precious and delicate nature of the gift of sight, in 1947 Mrs. Doheny created the organization named for her. Today, the Doheny Eye Institute serves thousands of patients in clinics around Los Angeles and Orange Counties and has emerged as a world leader in basic and clinical vision research and advanced patient care. The Institute's innovative research programs continually result in new diagnostic and treatment procedures and are respected internationally for research of the highest caliber, with direct impact on changing lives with improved sight In December 2013, UCLA’s Stein Eye Institute and the Doheny Eye Institute signed a long-term affiliation agreement. Under terms of the affiliation agreement there is a single integrated UCLA Department of Ophthalmology underlying both Institutes comprising Doheny-affiliated physicians and Stein physicians. The clinical enterprise will function as a single entity. Patients will encounter the same patient experience and range of services at any of the locations. Resources of both institutes will be dedicated to preeminence in patient care, research and education and will benefit the faculty of the UCLA Department of Ophthalmology.